Please update your browser.

Morgan Health’s mission is to accelerate the delivery of new care models that improve the quality, equity and affordability of employer-sponsored health care through investments, partnership, benefits improvements, and thought leadership. Morgan Health will focus on three strategic areas:
Health Care Innovation
The business unit is led by Dan Mendelson, CEO of Morgan Health, reporting to Peter Scher, Vice Chairman of JPMorgan Chase & Co. and a member of the firm’s Operating Committee.
Coverage and Insights

Morgan Health Joining $23 Million Funding Round for Embold Health
Morgan Health announced its investment in Embold Health, a physician-led analytics company that measures and creates transparency around provider performance.
Learn More >

Morgan Health | The Future of Health Care
In our first newsletter, Morgan Health illustrates the The Future of Health Care

Employers Should Expect More from the U.S. Health Care System
Six months post launch, Morgan Health has taken notable steps to improve employer-sponsored health care.
Learn More >

A Pathway for Coordinated, Affordable Employer-Sponsored Health Care
Despite employer-sponsored health insurance continuing to be the main source of coverage for working families in America, barriers related to cost, quality, support and equity remain being a significant challenge for advancement.

Morgan Health Invests $50 Million in Vera Whole Health
Morgan Health announced their first investment in Vera Whole Heath, a company focused on transforming how patients engage with health care, how providers deliver care, and how employers pay for care.
Morgan Health partners with Kaiser Permanente to tackle health equity in the CA region
Morgan Health’s partnership with Kaiser Permanente is allowing us to understand needs of JPMC employees by utilizing insights provided by Kaiser Permanente.
Learn More >
"We need to try to make the U.S. health care system work better. We have the best health care in the world in terms of doctors, hospitals, pharmaceutical and medical device companies, but we certainly do not have the best outcomes. Many of our problems have been around for a long time and are not aging well. There are ways we can make significant improvements and we intend to take a disciplined approach to solving some of these issues in a meaningful way."
_______
Jamie Dimon, Chairman and CEO, JPMorgan Chase & Co.